Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  Series C |

---

|  |  |  |
| --- | --- | --- |
|  | C/2023/1178 | 4.12.2023 |

Action brought on 18 October 2023 — Mendes v EUIPO — Actial Farmaceutica (BIFIDOBACTERIUM BREVE DSM24732)

(Case T-1041/23)

(C/2023/1178)

Language in which the application was lodged: English

Parties

Applicant: Mendes SA (Lugano, Switzerland) (represented by: M. Cavattoni, lawyer)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: Actial Farmaceutica Srl (Rome, Italy)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: European Union word mark BIFIDOBACTERIUM BREVE DSM24732 — European Union trade mark No 12 868 981

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 16 August 2023 in Case R 2246/2022-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | uphold its action; |

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order the other party to the proceedings to bear the costs and fees. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 7(1)(c) of Council Regulation (EC) No 207/2009; |

|  |  |
| --- | --- |
| — | Infringement of Article 7(1)(b) and (c) of Council Regulation (EC) No 207/2009; |

|  |  |
| --- | --- |
| — | Violation of the right to property of the applicant; |

|  |  |
| --- | --- |
| — | Infringement of Article 59(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)